Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Experimental Biology and Medicine (Maywood, N.J.)|June 26, 2021
KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancerXuyang Hou, Qiuguo Li, Leping Yang, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2011
Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the GallbladderZhi Yang, Zhulin Yang, Li Xiong, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significanceZhulin Yang, Daiqiang Li, Ziru Liu, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|December 15, 2015
LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal AdenocarcinomasYuan Luo, Zhulin Yang, Daiqiang Li, et al.Disease Markers|August 22, 2015
The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal AdenocarcinomasShan Liang, Zhulin Yang, Daiqiang Li, et al.Small (Weinheim an Der Bergstrasse, Germany)|October 13, 2017
T-Nb2 O5 /C Nanofibers Prepared through Electrospinning with Prolonged Cycle Durability for High-Rate Sodium-Ion Batteries Induced by PseudocapacitanceLeping Yang, Yuan-En Zhu, Jian Sheng, et al.The International Journal of Biochemistry & Cell Biology|February 26, 2020
Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cellsFanhua Kong, Xi Liu, Yan Zhou, et al.Cancer Medicine|December 6, 2020
HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3Xuyang Hou, Leping Yang, Kunpeng Wang, et al.Scientific Reports|March 5, 2021
The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017Mimi Zhai, Zhide Liu, Jianhai Long, et al.Cancer Biomarkers : Section a of Disease Markers|October 1, 2016
Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinomaHongliang Yao, Zhulin Yang, Ziru Liu, et al.Pageof 4